Diagnostics (Aug 2023)

Depression and Malnutrition for Prediction of Mortality after Transcatheter Aortic Valve Replacement: A Registry Study of a Tertiary Referral Hospital

  • Jolien Geers,
  • Karen Van den Bussche,
  • Bert Vandeloo,
  • Dorien M. Kimenai,
  • Ines Van Loo,
  • Vincent Michiels,
  • Daniele Plein,
  • Stefan Beckers,
  • Teun Muylle,
  • Siddhartha Lieten,
  • Bernard Cosyns,
  • Nathalie Compté,
  • Jean-François Argacha

DOI
https://doi.org/10.3390/diagnostics13152561
Journal volume & issue
Vol. 13, no. 15
p. 2561

Abstract

Read online

Moderate to severe frailty is a predictor of a poor outcome after transcatheter aortic valve replacement (TAVR), but little is known about the prognostic importance of different geriatric frailty markers in an overall fit or pre-frail geriatric population undergoing TAVR. This retrospective study aimed to examine the incremental value of adding patient frailty markers to conventional surgical risk score to predict all-cause mortality in relatively fit elderly patients undergoing TAVR. Overall patient frailty was assessed using the comprehensive geriatric assessment frailty index (CGA-FI). Multivariable Cox regression models were used to evaluate relationships of different geriatric frailty markers with all-cause mortality and single and combined frailty models were compared to a baseline model that included EuroSCORE II factors. One hundred relatively fit geriatric patients (84 ± 4 years old, mean CGA-FI 0.14 ± 0.05) were included, and 28% died during a median follow-up of 24 months. After adjustment, risk of depression (geriatric depression scale 15 (GDS-15)) and malnutrition remained significantly associated with all-cause mortality (HR 4.381, 95% CI 1.787–10.743; p = 0.001 and HR 3.076, 95% CI 1.151–8.217; p = 0.025, respectively). A combined frailty marker model including both GDS-15 and malnutrition on top of EuroSCORE II improved the discriminative ability to predict all-cause mortality (change in c-index: + 0.044). Screening for those frailty markers on top of the traditionally used EuroSCORE II may improve risk stratification and prognosis in relatively fit geriatric patients undergoing TAVR.

Keywords